Indonesia Malaysia Vietnam Thailand Philippines Australia New Zealand China Korea And India Veterinary Medicine Market
Taille du marché en milliards USD
TCAC :
% 
6,811.52
2022
2030
 Période de prévision |
2023 –2030 |
 Taille du marché (année de référence) |
|
 Taille du marché (année de prévision) |
Dollars américains 6,811.52 |
 TCAC |
% |
| Principaux acteurs du marché |
Marché des médicaments vétérinaires en Indonésie, en Malaisie, au Vietnam, en Thaïlande, aux Philippines, en Australie, en Nouvelle-Zélande, en Chine, en Corée et en Inde, par produit (vaccins, médicaments et suppléments), type d'animal (production alimentaire et animaux de compagnie), dosage (solide, liquide et semi-solide), voie d'administration (orale, parentérale et topique), application (fièvre aphteuse, maladies auto-immunes, maladies bactériennes, infection à helminthes, fièvre catarrhale, dermatite atopique canine et autres), utilisateur final (hôpitaux, cliniques vétérinaires, établissements de soins à domicile et laboratoires), canal de distribution (appel d'offres direct, vente au détail, pharmacie en ligne et autres) - Tendances et prévisions de l'industrie jusqu'en 2030.
Analyse et taille du marché des médicaments vétérinaires en Indonésie, en Malaisie, au Vietnam, en Thaïlande, aux Philippines, en Australie, en Nouvelle-Zélande, en Chine, en Corée et en Inde
Le marché des médicaments vétérinaires d'Indonésie, de Malaisie, du Vietnam, de Thaïlande, des Philippines, d'Australie, de Nouvelle-Zélande, de Chine, de Corée et d'Inde est fragmenté par nature, car il se compose de nombreux acteurs mondiaux tels que Zoetis Services LLC, Boehringer Ingelheim International GmbH, Virbac, Ceva et Dechra Pharmaceuticals PLC, entre autres. La présence de ces entreprises produit des prix compétitifs pour les médicaments vétérinaires dans toute la région. En raison de la présence de ces acteurs aux niveaux régional et international, les fournisseurs et les fabricants proposent des produits avec des spécifications et des caractéristiques différentes pour tous les budgets. L'augmentation du nombre d'animaux de compagnie et l'humanisation des animaux de compagnie stimulent la croissance du marché. De plus, la prévalence croissante des maladies animales devrait stimuler la croissance du marché.
Data Bridge Market Research analyse que le marché de la médecine vétérinaire en Indonésie, en Malaisie, au Vietnam, en Thaïlande, aux Philippines, en Australie, en Nouvelle-Zélande, en Chine, en Corée et en Inde devrait atteindre une valeur de 6 811,52 millions USD d'ici 2030, à un TCAC de 10,1 % au cours de la période de prévision. Ce rapport de marché couvre également en profondeur l'analyse des prix et les avancées technologiques.
|
Rapport métrique |
Détails |
|
Période de prévision |
2023 à 2030 |
|
Année de base |
2022 |
|
Années historiques |
2021 (personnalisable de 2015 à 2020) |
|
Unités quantitatives |
Chiffre d'affaires en millions, volumes en unités, prix en USD |
|
Segments couverts |
Produit ( vaccins , médicaments et suppléments), type d'animal (production alimentaire et animaux de compagnie), dosage (solide, liquide et semi-solide), voie d'administration (orale, parentérale et topique), application (fièvre aphteuse, maladies auto-immunes, maladies bactériennes, infection par les helminthes, fièvre catarrhale, dermatite atopique canine et autres), utilisateur final (hôpitaux, cliniques vétérinaires, établissements de soins à domicile et laboratoires), canal de distribution (appel d'offres direct, vente au détail, pharmacie en ligne et autres) |
|
Pays couverts |
Inde, Australie, Chine, Indonésie, Malaisie, Nouvelle-Zélande, Corée, Vietnam, Thaïlande et Philippines |
|
Acteurs du marché couverts |
Zoetis Services LLC (États-Unis), Boehringer Ingelheim International GmbH (Allemagne), Virbac (France), Ceva (France), Dechra Pharmaceuticals PLC (Angleterre), HUVEPHARMA (Bulgarie), Phibro Animal Health Corporation (États-Unis), Kemin Industries, Inc. (États-Unis), Vetoquinol (France), Mankind Pharma (Inde), Indian Immunologicals Ltd. (Inde), ECO Animal Health Ltd (Royaume-Uni), Biologische Heilmittel Heel GmbH, Alivira Animal Health Limited, Jurox Pty Limited, Biogénesis Bagó (Allemagne), Bentoli (États-Unis), Inovet (Hongrie), MSD Animal Health (États-Unis), Zovix Pharmaceuticals (Inde) et Valor Chemical Co., Ltd (Chine) entre autres |
Définition du marché
Le marché des médicaments vétérinaires désigne l'industrie qui développe, produit et vend des médicaments et autres produits de santé pour les animaux. Cela comprend les médicaments pour les animaux de compagnie, le bétail et d'autres animaux. Le marché est stimulé par la demande croissante de services et de produits de santé animale et par la prise de conscience croissante de l'importance de la santé et du bien-être des animaux. Le marché des médicaments vétérinaires comprend divers produits tels que les vaccins, les antibiotiques , les antiparasitaires et les anti-inflammatoires. Le marché est également influencé par des facteurs tels que les réglementations gouvernementales, les avancées technologiques et le niveau de concurrence.
Dynamique du marché des médicaments vétérinaires en Indonésie, en Malaisie, au Vietnam, en Thaïlande, aux Philippines, en Australie, en Nouvelle-Zélande, en Chine, en Corée et en Inde
Cette section traite de la compréhension des moteurs, des avantages, des opportunités, des contraintes et des défis du marché. Tout cela est discuté en détail ci-dessous :
CONDUCTEURS
Augmentation du nombre de propriétaires d'animaux de compagnie et humanisation des animaux
L’expérience de posséder un animal de compagnie existe dans de nombreuses cultures du monde. Dans de nombreux pays, comme l’Inde, la Chine, la Corée, la Thaïlande, le Vietnam et l’Australie, une majorité de personnes vivent avec des animaux de compagnie. Le nombre d’animaux de compagnie augmente en raison d’une combinaison de facteurs tels que le désir de compagnie, les avantages pour la santé, l’évolution des attitudes envers les animaux de compagnie et l’augmentation du revenu disponible. Les animaux de compagnie offrent de la compagnie et un soutien émotionnel, ce qui est particulièrement important pour les personnes qui vivent seules ou qui ont des interactions sociales limitées. Des études ont montré que posséder un animal de compagnie peut avoir de nombreux avantages pour la santé, notamment une baisse de la tension artérielle, une réduction du niveau de stress et une amélioration de la santé mentale. Ainsi, de plus en plus de personnes s’installent dans les zones urbaines, elles peuvent se sentir isolées et déconnectées de la nature. Posséder un animal de compagnie peut procurer un sentiment de connexion avec le monde naturel et une source de réconfort.
À mesure que le revenu disponible augmente, les gens peuvent avoir plus d’argent à dépenser pour les animaux de compagnie et les dépenses liées aux animaux de compagnie, comme la nourriture, les jouets et les soins de santé. Les attitudes envers les animaux de compagnie ont changé au fil du temps, de nombreuses personnes considérant désormais les animaux de compagnie comme des membres de la famille plutôt que comme de simples animaux. L’essor des médias sociaux a également contribué à la popularité de la possession d’animaux de compagnie, de nombreuses personnes partageant des photos et des histoires de leurs animaux en ligne et se connectant avec d’autres propriétaires d’animaux. De même, l’humanisation des animaux de compagnie fait référence à la tendance à traiter les animaux de compagnie comme des membres de la famille et à leur fournir le même niveau de soins et d’attention que les membres de la famille humaine. Cela comprend la fourniture d’une nourriture, de soins de santé et de services de toilettage de haute qualité, et le traitement des animaux de compagnie comme des compagnons et des sources de soutien émotionnel.
Ainsi, de plus en plus de personnes adoptent des animaux de compagnie, ce qui accroît la demande globale de médicaments vétérinaires pour répondre aux besoins de ces animaux. Les propriétaires d'animaux de compagnie sont de plus en plus intéressés par les soins de santé préventifs pour leurs animaux, qui impliquent des contrôles et des vaccinations réguliers. Cela conduit à une demande accrue de médicaments vétérinaires tels que les vaccins et les produits préventifs contre les puces et les tiques. Dans l'ensemble, l'adoption d'animaux de compagnie entraîne une demande accrue de médicaments vétérinaires, car les propriétaires d'animaux cherchent à fournir à leurs animaux les meilleurs soins et traitements possibles. Cette tendance devrait se poursuivre à mesure que le nombre de propriétaires d'animaux de compagnie continue de croître et que les propriétaires d'animaux de compagnie s'investissent davantage dans la santé et le bien-être de leurs animaux.
Prévalence croissante des maladies animales
L'augmentation des maladies animales est liée à l'augmentation des médicaments vétérinaires, car à mesure que le nombre de maladies animales augmente, la demande de traitements efficaces et de mesures préventives augmente également. Cela conduit au développement et à la production de davantage de médicaments vétérinaires pour traiter les diverses maladies et affections affectant les animaux.
L’utilisation de médicaments vétérinaires est essentielle pour gérer et contrôler les maladies animales, et leur efficacité peut contribuer à réduire la propagation des maladies et à améliorer la santé animale. Par conséquent, le besoin croissant de médicaments vétérinaires est directement lié au nombre croissant de maladies animales et à la nécessité d’interventions efficaces pour les gérer.
Par exemple,
- En décembre 2022, selon le NCBI, la Malaisie a connu une épidémie de grippe aviaire hautement pathogène (HPAI) 2021, une maladie virale affectant les oiseaux. L'épidémie a entraîné l'abattage de milliers d'oiseaux, entraînant une perte importante pour l'industrie avicole du pays
- En septembre 2021, un article publié dans Springer Nature indiquait qu'en 2019, la Chine avait connu une épidémie de peste porcine africaine (PPA), une maladie hautement contagieuse qui touche les porcs. L'épidémie a entraîné l'abattage de millions de porcs, entraînant une perte importante pour l'industrie porcine du pays.
D'après les exemples ci-dessus, on peut conclure que la prévalence croissante des maladies animales stimule la croissance du marché de la médecine vétérinaire en Indonésie, en Malaisie, au Vietnam, en Thaïlande, aux Philippines, en Australie, en Nouvelle-Zélande, en Chine, en Corée et en Inde au cours de la période de prévision.
OPPORTUNITÉ
Développement de médicaments vétérinaires innovants et personnalisés
Le développement de nouveaux médicaments vétérinaires personnalisés représente une opportunité importante pour le marché des médicaments vétérinaires. La médecine vétérinaire personnalisée fait référence à l'utilisation de thérapies ciblées basées sur la constitution génétique d'un animal spécifique, ses antécédents médicaux et d'autres facteurs. Cette approche permet un traitement plus précis et efficace, avec moins d'effets secondaires. Le développement de médicaments vétérinaires personnalisés est étroitement lié aux progrès de la génomique et d'autres domaines de la recherche biomédicale. Ces progrès ont permis aux chercheurs de mieux comprendre les causes sous-jacentes des maladies chez les animaux et de développer des thérapies ciblées qui s'attaquent à ces causes. En outre, la demande de médicaments vétérinaires personnalisés parmi les propriétaires d'animaux de compagnie et les vétérinaires est croissante.
Cette demande stimule l’innovation sur le marché des médicaments vétérinaires, avec le développement de nouveaux produits et thérapies pour traiter un large éventail de pathologies. En outre, le développement de médicaments vétérinaires personnalisés stimule également la croissance du marché du diagnostic animal. Comme de plus en plus d’animaux sont diagnostiqués avec des maladies ou des pathologies spécifiques, il existe un besoin croissant de tests de diagnostic capables d’identifier précisément ces pathologies. Dans l’ensemble, le développement de médicaments vétérinaires nouveaux et personnalisés crée d’importantes opportunités de croissance sur le marché des médicaments vétérinaires. À mesure que la recherche et le développement continuent de progresser, nous pouvons nous attendre à une innovation et une croissance continues dans ce secteur important.
RETENUE / DÉFI
Coût élevé des médicaments vétérinaires
Les prix élevés des médicaments vétérinaires peuvent limiter l’accessibilité financière des propriétaires d’animaux de compagnie et des éleveurs, ce qui peut entraîner une baisse de la demande pour ces médicaments. Cela peut entraîner une baisse des revenus des fabricants et des distributeurs de médicaments vétérinaires. Lorsque les propriétaires d’animaux de compagnie ou les éleveurs ne peuvent pas se permettre le coût élevé des médicaments vétérinaires, ils risquent de ne pas respecter le schéma thérapeutique recommandé. Cela peut entraîner de mauvais résultats pour la santé des animaux et une réduction de l’efficacité du médicament.
Les prix élevés des médicaments vétérinaires peuvent attirer de nouveaux entrants sur le marché qui proposent des alternatives moins chères. Cela pourrait accroître la concurrence et réduire la part de marché des fabricants existants. Les prix élevés des médicaments vétérinaires peuvent attirer l’attention des autorités réglementaires et conduire à une réglementation accrue du marché. Cela pourrait augmenter les coûts pour les fabricants et les distributeurs, ce qui entraînerait des prix plus élevés pour les consommateurs. Globalement, le coût élevé des médicaments vétérinaires peut limiter la croissance du marché en réduisant la demande, en augmentant la concurrence et en attirant l’attention des autorités réglementaires.
Impact post-COVID-19 sur le marché des médicaments vétérinaires en Indonésie, en Malaisie, au Vietnam, en Thaïlande, aux Philippines, en Australie, en Nouvelle-Zélande, en Chine, en Corée et en Inde
La COVID-19 a eu un impact négatif sur le marché des médicaments vétérinaires en Indonésie, en Malaisie, au Vietnam, en Thaïlande, aux Philippines, en Australie, en Nouvelle-Zélande, en Chine, en Corée et en Inde. Les restrictions liées au confinement ont entraîné l'apparition de divers problèmes tels que la diminution des moyens de transport et de communication ainsi que la diminution des visites dans les hôpitaux vétérinaires, retardant ainsi les procédures de traitement.
La pandémie de COVID-19 a eu un impact négatif sur le marché. Cependant, l'augmentation du soutien gouvernemental et les progrès dans les médicaments et technologies vétérinaires devraient offrir des opportunités lucratives de croissance du marché. En outre, l'augmentation des partenariats, des acquisitions et de la collaboration entre les acteurs du marché devrait alimenter davantage la croissance du marché. En outre, la croissance a été élevée depuis l'ouverture du marché après COVID-19, et on s'attend à ce qu'il y ait une croissance considérable dans le secteur. Les acteurs du marché mènent de multiples activités pour améliorer les médicaments vétérinaires. Grâce à cela, les entreprises apporteront des progrès et de l'innovation au marché.
Développements récents
- En avril 2023, MSD Animal Health a reçu de la Commission européenne l'autorisation de mise sur le marché du vaccin vivant BOVILIS Nasalgen-C pour les bovins. Cela a aidé l'entreprise à établir sa présence mondiale sur le marché.
- En septembre 2022, Zoetis Services LLC a annoncé avoir finalisé l'acquisition de Jurox, une société privée de santé animale qui développe, fabrique et commercialise une large gamme de médicaments vétérinaires pour le traitement du bétail et des animaux de compagnie.
Portée du marché de la médecine vétérinaire en Indonésie, en Malaisie, au Vietnam, en Thaïlande, aux Philippines, en Australie, en Nouvelle-Zélande, en Chine, en Corée et en Inde
Le marché des médicaments vétérinaires d'Indonésie, de Malaisie, du Vietnam, de Thaïlande, des Philippines, d'Australie, de Nouvelle-Zélande, de Chine, de Corée et d'Inde est segmenté en sept segments notables en fonction du produit, du type d'animal, du dosage, de la voie d'administration, de l'application, de l'utilisateur final et du canal de distribution. La croissance parmi ces segments vous aidera à analyser les segments de croissance limités dans les industries et fournira aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour les aider à prendre des décisions stratégiques pour identifier les principales applications du marché.
Produit
- Vaccins
- Médicament
- Suppléments
En fonction du produit, le marché est segmenté en vaccins, médicaments et suppléments.
Type d'animal
- Production alimentaire
- Animaux de compagnie
En fonction du type d’animal, le marché est segmenté en production alimentaire et animaux de compagnie.
Dosage
- Solide
- Liquide
- Semi-solide
En fonction du dosage, le marché est segmenté en solide, liquide et semi-solide.
Voie d'administration
- Oral
- Parentérale
- Topique
En fonction de la voie d’administration, le marché est segmenté en voie orale, parentérale et topique.
Application
- Fièvre aphteuse
- Maladies auto-immunes
- Maladies bactériennes
- Infection par les helminthes
- Fièvre catarrhale
- Dermatite atopique canine
- Autres
En fonction des applications, le marché est segmenté en fièvre aphteuse, maladies auto-immunes, maladies bactériennes, infection par les helminthes, fièvre catarrhale, dermatite atopique canine et autres.
Utilisateur final
- Hôpitaux
- Cliniques vétérinaires
- Cadres de soins à domicile
- Laboratoires
En fonction de l’utilisateur final, le marché est segmenté en hôpitaux, cliniques vétérinaires, établissements de soins à domicile et laboratoires.
Canal de distribution
- Appel d'offres direct
- Ventes au détail
- Pharmacie en ligne
- Autres
En fonction du canal de distribution, le marché est segmenté en appels d'offres directs, ventes au détail, pharmacies en ligne et autres.
Analyse/perspectives du marché des médicaments vétérinaires en Indonésie, en Malaisie, au Vietnam, en Thaïlande, aux Philippines, en Australie, en Nouvelle-Zélande, en Chine, en Corée et en Inde
Le marché des médicaments vétérinaires d'Indonésie, de Malaisie, du Vietnam, de Thaïlande, des Philippines, d'Australie, de Nouvelle-Zélande, de Chine, de Corée et d'Inde est analysé et des informations sur la taille du marché et les tendances sont fournies par pays, produit, type d'animal, dosage, voie d'administration, application, utilisateur final et canal de distribution comme référencé ci-dessus. Les pays couverts dans ce rapport de marché sont l'Inde, l'Australie, la Chine, l'Indonésie, la Malaisie, la Nouvelle-Zélande, la Corée, le Vietnam, la Thaïlande et les Philippines. L'Inde domine le marché avec la plus grande part de marché. Cette part est attribuable à la présence d'acteurs clés du marché tels que Zoetis Services LLC, Boehringer Ingelheim International GmbH., Virbac, Ceva et Dechra Pharmaceuticals PLC. entre autres. L'augmentation du nombre d'animaux de compagnie et l'humanisation des animaux de compagnie devraient alimenter la croissance du marché au cours de la période de prévision dans cette région.
La section par pays du rapport fournit également des facteurs individuels ayant un impact sur le marché et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques, l'analyse des cinq forces de Porter et les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour chaque pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte lors de l'analyse prévisionnelle des données nationales.
Paysage concurrentiel et analyse des parts de marché de la médecine vétérinaire en Indonésie, en Malaisie, au Vietnam, en Thaïlande, aux Philippines, en Australie, en Nouvelle-Zélande, en Chine, en Corée et en Inde
Le paysage concurrentiel du marché des médicaments vétérinaires en Indonésie, en Malaisie, au Vietnam, en Thaïlande, aux Philippines, en Australie, en Nouvelle-Zélande, en Chine, en Corée et en Inde fournit des détails sur le concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché.
Français Certains des principaux acteurs du marché opérant sur le marché de la médecine vétérinaire en Indonésie, en Malaisie, au Vietnam, en Thaïlande, aux Philippines, en Australie, en Nouvelle-Zélande, en Chine, en Corée et en Inde sont Zoetis Services LLC (États-Unis), Boehringer Ingelheim International GmbH. (Allemagne), Virbac (France), Ceva (France), Dechra Pharmaceuticals PLC (Angleterre), HUVEPHARMA (Bulgarie), Phibro Animal Health Corporation (États-Unis), Kemin Industries, Inc. (États-Unis), Vetoquinol (France), Mankind Pharma (Inde), Indian Immunologicals Ltd. (Inde), ECO Animal Health Ltd (Royaume-Uni), Biologische Heilmittel Heel GmbH, Alivira Animal Health Limited, Jurox Pty Limited, Biogénesis Bagó (Allemagne), Bentoli (États-Unis), Inovet (Hongrie), MSD Animal Health (États-Unis), Zovix Pharmaceuticals (Inde) et Valor Chemical Co., Ltd (Chine) entre autres.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 CURRENCY AND PRICING
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
5 INDUSTRY INSIGHTS
5.1 PATENT ANALYSIS
5.2 DRUG TREATMENT RATE BY MATURED MARKETS
5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES
5.4 PATIENT FLOW DIAGRAM
5.5 KEY PRICING STRATEGIES
5.6 KEY PATIENT ENROLLMENT STRATEGIES
6 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PET OWNERSHIP AND HUMANIZATION OF PETS
7.1.2 GROWING PREVALENCE OF ANIMAL DISEASES
7.1.3 ADVANCEMENTS IN VETERINARY MEDICINE AND TECHNOLOGY
7.1.4 INCREASING GOVERNMENT INITIATIVES FOR ANIMAL HEALTH AND WELFARE
7.2 RESTRAINTS
7.2.1 HIGH COST OF VETERINARY MEDICINES
7.2.2 STRINGENT REGULATORY REQUIREMENTS FOR APPROVAL
7.3 OPPORTUNITIES
7.3.1 DEVELOPMENT OF NOVEL AND PERSONALIZED VETERINARY MEDICINES
7.3.2 INCREASING TREND TOWARDS PREVENTIVE HEALTHCARE FOR ANIMALS
7.3.3 RISING DEMAND FOR NATURAL AND HERBAL VETERINARY MEDICINES
7.4 CHALLENGES
7.4.1 LIMITED R&D FUNDING FOR VETERINARY MEDICINES
7.4.2 LACK OF SKILLED VETERINARY PROFESSIONALS
8 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 VACCINES
8.2.1 LIVE ATTENUATED VACCINES
8.2.2 TOXOID VACCINES
8.2.3 RECOMBINANT VACCINES
8.2.4 INACTIVATED VACCINES
8.2.5 OTHERS
8.3 MEDICATION
8.3.1 ANTIBIOTICS
8.3.1.1 AMOXICILLIN
8.3.1.2 AMPICILLIN
8.3.1.3 LINCOMYCIN
8.3.1.4 COLISTIN
8.3.1.5 GENTAMICIN
8.3.1.6 TETRACYCLINE
8.3.1.7 DOXYCYCLINE
8.3.1.8 TYLOSIN
8.3.1.9 OTHERS
8.3.2 ANALGESICS
8.3.2.1 ANTI-INFLAMMATORY (NSAIDS)
8.3.2.2 ACETAMINOPHEN
8.3.2.3 FIROCOXIB
8.3.2.4 MELOXICAM
8.3.2.5 CARPROFEN
8.3.2.6 DERACOXIB
8.3.2.7 PHENYLBUTAZONE
8.3.2.8 OTHERS
8.3.2.9 OPIOIDS
8.3.2.10 MU AGONISTS
8.3.2.10.1 MORPHINE
8.3.2.10.2 OXYMORPHONE
8.3.2.10.3 METHADONE
8.3.2.10.4 MEPERIDINE
8.3.2.10.5 OTHERS
8.3.2.11 KAPPA AGONIST-MU ANTAGONIST
8.3.2.11.1 BUTORPHANOL
8.3.2.11.2 OTHERS
8.3.2.12 PARTIAL MU AGONIST
8.3.2.13 BUPRENORPHINE
8.3.2.14 OTHERS
8.3.3 PARASITICIDES
8.3.3.1 AMPROLIUM
8.3.3.2 BENZIMIDAZOLES
8.3.3.3 NITROIMIDAZOLES
8.3.3.4 ALBENDAZOLE
8.3.3.5 PIPERAZINE
8.3.3.6 DELTAMETHRIN
8.3.3.7 LEVAMISOLE
8.3.3.8 OTHERS
8.3.4 ANTIHISTAMINES
8.3.4.1 CETIRIZINE
8.3.4.2 BROMPHENIRAMINE
8.3.4.3 DIPHENHYDRAMINE
8.3.4.4 TERFENADINE
8.3.4.5 TRIMEPRAZINE
8.3.4.6 OTHERS
8.3.5 CORTICOSTEROIDS
8.3.5.1 PREDNISONE
8.3.5.2 PREDNISOLONE
8.3.5.3 DEXAMETHASON
8.3.5.4 OTHERS
8.3.6 ANTIBLOAT
8.3.6.1 DOCUSATE
8.3.6.2 SIMETHICONE
8.3.6.3 OTHERS
8.3.7 HORMONAL
8.3.7.1 EQUINE CHORIONIC GONADOTROPIN
8.3.7.2 CLOPROSTENOL
8.3.7.3 OXYTOCIN
8.3.7.4 OTHERS
8.4 SUPPLEMENTS
8.4.1 VITAMINS
8.4.2 MINERALS
8.4.3 MOLD INHIBITOR
8.4.4 TOXIN BINDER
8.4.5 FEED ACIDIFIERS
8.4.6 OTHERS
9 INDONESIA, MALAYSIA, VIETNAM,THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE
9.1 OVERVIEW
9.2 FOOD PRODUCTION
9.2.1 POULTRY
9.2.2 CATTLE
9.2.3 SWINE
9.2.4 FISH
9.2.5 OTHERS
9.3 COMPANION ANIMALS
9.3.1 DOGS
9.3.2 CATS
9.3.3 HORSES
9.3.4 OTHERS
10 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA & INDIA VETERINARY MEDICINE MARKET, BY DOSAGE
10.1 OVERVIEW
10.2 SOLID
10.2.1 TABLET
10.2.2 POWDER
10.2.3 OTHERS
10.3 LIQUID
10.3.1 SYRUP
10.3.2 SUSPENSION
10.3.3 SOLUTION
10.3.4 BOLUS
10.3.5 OTHERS
10.4 SEMI-SOLID
10.4.1 GEL
10.4.2 CREAM
10.4.3 OTHERS
11 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA & INDIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION
11.1 OVERVIEW
11.2 ORAL
11.3 PARENTERAL
11.4 TOPICAL
12 INDONESIA, MALAYSIA, VIETNAM,THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 FOOT AND MOUTH DISEASE
12.3 AUTOIMMUNE DISEASES
12.4 BACTERIAL DISEASES
12.5 HELMINTHES INFECTION
12.6 BLUETONGUE
12.7 CANINE ATOPIC DERMATITIS
12.8 OTHERS
13 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA & INDIA VETERINARY MEDICINE MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 VETERINARY CLINICS
13.4 HOMECARE SETTINGS
13.5 LABORATORIES
14 INDONESIA, MALAYSIA, VIETNAM,THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAIL SALES
14.4 ONLINE PHARMACY
14.5 OTHERS
15 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: INDIA
15.2 COMPANY SHARE ANALYSIS: AUSTRALIA
15.3 COMPANY SHARE ANALYSIS: CHINA
15.4 COMPANY SHARE ANALYSIS: INDONESIA
15.5 COMPANY SHARE ANALYSIS: MALAYSIA
15.6 COMPANY SHARE ANALYSIS: NEW ZEALAND
15.7 COMPANY SHARE ANALYSIS: KOREA
15.8 COMPANY SHARE ANALYSIS: VIETNAM
15.9 COMPANY SHARE ANALYSIS: THAILAND
15.1 COMPANY SHARE ANALYSIS: PHILIPPINES
16 COMPANY PROFILE
16.1 ZOETIS SERVICES LLC
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENTS
16.2 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 VIRBAC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENT
16.4 CEVA
16.4.1 COMPANY SNAPSHOT
16.4.2 PRODUCT PORTFOLIO
16.4.3 RECENT DEVELOPMENTS
16.5 DECHRA PHARMACEUTICALS PLC
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 ALIVIRA ANIMAL HEALTH LIMITED
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 BENTOLI
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 BIOGÉNESIS BAGÓ
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 BIOLOGISCHE HEILMITTEL HEEL GMBH
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 ECO ANIMAL HEALTH LTD
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 HUVEPHARMA
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 INDIAN IMMUNOLOGICALS LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 INOVET
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 JUROX PTY LIMITED.
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 KEMIN INDUSTRIES, INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 MANKIND PHARMA
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENT
16.17 MSD ANIMAL HEALTH
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 PHIBRO ANIMAL HEALTH CORPORATION.
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 VALOR CHEMICAL CO., LTD
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 VETOQUINOL
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 ZOVIX PHARMACEUTICALS.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Liste des tableaux
TABLE 1 INDIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 AUSTRALIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 3 CHINA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 INDONESIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 5 MALAYSIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 6 NEW ZEALAND VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 KOREA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 8 VIETNAM VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 9 THAILAND VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 10 PHILIPPINES VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 INDIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 12 AUSTRALIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 13 CHINA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 14 INDONESIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 15 MALAYSIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 16 NEW ZEALAND VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 17 KOREA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 18 VIETNAM VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 19 THAILAND VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 20 PHILIPPINES VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 21 INDIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 22 AUSTRALIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 23 CHINA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 24 INDONESIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 25 MALAYSIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 26 NEW ZEALAND MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 27 KOREA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 28 VIETNAM MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 29 THAILAND MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 30 PHILIPPINES MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 31 INDIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 32 AUSTRALIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 33 CHINA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 34 INDONESIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 35 MALAYSIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 36 NEW ZEALAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 37 KOREA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 38 VIETNAM ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 39 THAILAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 40 PHILIPPINES ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 41 INDIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 42 AUSTRALIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 43 CHINA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 44 INDONESIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 45 MALAYSIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 46 NEW ZEALAND ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 47 KOREA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 48 VIETNAM ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 THAILAND ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 50 PHILIPPINES ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 INDIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 52 AUSTRALIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 53 CHINA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 54 INDONESIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 55 MALAYSIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 56 NEW ZEALAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 57 KOREA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 58 VIETNAM ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 59 THAILAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 60 PHILIPPINES ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 61 INDIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 AUSTRALIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 CHINA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 INDONESIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 65 MALAYSIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 66 NEW ZEALAND OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 67 KOREA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 68 VIETNAM OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 69 THAILAND OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 70 PHILIPPINES OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 71 INDIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 72 AUSTRALIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 73 CHINA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 74 INDONESIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 75 MALAYSIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 76 NEW ZEALAND MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 77 KOREA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 78 VIETNAM MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 79 THAILAND MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 80 PHILIPPINES MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 81 INDIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 82 AUSTRALIA KAPPA AGONIST-MU ANTAGONIST S IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 CHINA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 84 INDONESIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 85 MALAYSIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 86 NEW ZEALAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 87 KOREA KAPPA AGONIST-MU ANTAGONIST S IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 88 VIETNAM KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 89 THAILAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 90 PHILIPPINES KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 91 INDIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 92 AUSTRALIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 CHINA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 94 INDONESIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 95 MALAYSIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 NEW ZEALAND PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 KOREA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 VIETNAM PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 99 THAILAND PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 100 PHILIPPINES PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 101 INDIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 102 AUSTRALIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 103 CHINA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 104 INDONESIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 105 MALAYSIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 106 NEW ZEALAND PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 107 KOREA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 108 VIETNAM PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 109 THAILAND PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 110 PHILIPPINES PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 111 INDIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 112 AUSTRALIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 113 CHINA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 114 INDONESIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 115 MALAYSIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 116 NEW ZEALAND ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 117 KOREA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 118 VIETNAM ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 119 THAILAND ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 120 PHILIPPINES ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 121 INDIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 122 AUSTRALIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 123 CHINA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 124 INDONESIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 125 MALAYSIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 126 NEW ZEALAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 127 KOREA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 128 VIETNAM ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 129 THAILAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 130 PHILIPPINES ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 131 INDIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 132 AUSTRALIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 133 CHINA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 134 INDONESIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 135 MALAYSIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 136 NEW ZEALAND ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 137 KOREA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 138 VIETNAM ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 139 THAILAND ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 140 PHILIPPINES ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 141 INDIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 142 AUSTRALIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 143 CHINA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 144 INDONESIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 145 MALAYSIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 146 NEW ZEALAND HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 147 KOREA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 148 VIETNAM HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 149 THAILAND HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 150 PHILIPPINES HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 151 INDIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 152 AUSTRALIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 153 CHINA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 154 INDONESIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 155 MALAYSIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 156 NEW ZEALAND SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 157 KOREA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 158 VIETNAM SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 159 THAILAND SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 160 PHILIPPINES SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 161 INDIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 162 AUSTRALIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 163 CHINA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 164 INDONESIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 165 MALAYSIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 166 NEW ZEALAND VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 167 KOREA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 168 VIETNAM VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 169 THAILAND VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 170 PHILIPPINES VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 171 INDIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 172 AUSTRALIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 173 CHINA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 174 INDONESIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 175 MALAYSIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 176 NEW ZEALAND FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 177 KOREA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 178 VIETNAM FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 179 THAILAND FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 180 PHILIPPINES FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 181 INDIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 182 AUSTRALIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 183 CHINA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 184 INDONESIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 185 MALAYSIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 186 NEW ZEALAND COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 187 KOREA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 188 VIETNAM COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 189 THAILAND COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 190 PHILIPPINES COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 191 INDIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 192 AUSTRALIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 193 CHINA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 194 INDONESIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 195 MALAYSIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 196 NEW ZEALAND VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 197 KOREA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 198 VIETNAM VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 199 THAILAND VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 200 PHILIPPINES VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 201 INDIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 202 AUSTRALIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 203 CHINA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 204 INDONESIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 205 MALAYSIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 206 NEW ZEALAND SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 207 KOREA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 208 VIETNAM SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 209 THAILAND SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 210 PHILIPPINES SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 211 INDIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 212 AUSTRALIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 213 CHINA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 214 INDONESIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 215 MALAYSIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 216 NEW ZEALAND LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 217 KOREA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 218 VIETNAM LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 219 THAILAND LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 220 PHILIPPINES LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 221 INDIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 222 AUSTRALIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 223 CHINA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 224 INDONESIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 225 MALAYSIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 226 NEW ZEALAND SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 227 KOREA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 228 VIETNAM SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 229 THAILAND SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 230 PHILIPPINES SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 231 INDIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 232 AUSTRALIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 233 CHINA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 234 INDONESIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 235 MALAYSIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 236 NEW ZEALAND VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 237 KOREA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 238 VIETNAM VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 239 THAILAND VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 240 PHILIPPINES VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 241 INDIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 242 AUSTRALIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 243 CHINA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 INDONESIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 245 MALAYSIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 246 NEW ZEALAND VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 247 KOREA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 VIETNAM VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 249 THAILAND VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 PHILIPPINES VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 251 INDIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 252 AUSTRALIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 253 CHINA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 254 INDONESIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 255 MALAYSIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 256 NEW ZEALAND VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 257 KOREA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 258 VIETNAM VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 259 THAILAND VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 260 PHILIPPINES VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 261 INDIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 262 AUSTRALIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 263 CHINA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 264 INDONESIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 265 MALAYSIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 266 NEW ZEALAND VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 267 KOREA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 268 VIETNAM VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 269 THAILAND VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 270 PHILIPPINES VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
Liste des figures
FIGURE 1 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: SEGMENTATION
FIGURE 2 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: DATA TRIANGULATION
FIGURE 3 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: DROC ANALYSIS
FIGURE 4 INDIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 5 AUSTRALIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 6 CHINA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 7 INDONESIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 8 MALAYSIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 9 NEW ZEALAND VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 10 KOREA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 11 VIETNAM VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 12 THAILAND VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 13 PHILIPPINES VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 14 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 15 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 16 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: MARKET END USER COVERAGE GRID
FIGURE 17 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: DBMR MARKET POSITION GRID
FIGURE 18 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: SEGMENTATION
FIGURE 19 RISING PET OWNERSHIP AND HUMANIZATION OF PET IS EXPECTED TO DRIVE THE GROWTH OF THE INDIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 20 GROWING PREVALENCE OF ANIMAL DISEASES IS EXPECTED TO DRIVE THE GROWTH OF AUSTRALIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 21 ADVANCEMENTS IN VETERINARY MEDICINE AND TECHNOLOGY IS EXPECTED TO DRIVE THE GROWTH OF CHINA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 22 INCREASING GOVERNMENT INITIATIVES FOR ANIMAL HEALTH AND WELFARE IS EXPECTED TO DRIVE THE GROWTH OF INDONESIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 23 RISING PET OWNERSHIP AND HUMANIZATION OF PET IS EXPECTED TO DRIVE THE GROWTH OF MALAYSIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 24 GROWING PREVALENCE OF ANIMAL DISEASES IS EXPECTED TO DRIVE THE GROWTH OF NEW ZEALAND VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 25 ADVANCEMENTS IN VETERINARY MEDICINE AND TECHNOLOGY IS EXPECTED TO DRIVE THE GROWTH OF KOREA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 26 INCREASING GOVERNMENT INITIATIVES FOR ANIMAL HEALTH AND WELFARE IS EXPECTED TO DRIVE THE GROWTH OF VIETNAM VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 27 RISING PET OWNERSHIP AND HUMANIZATION OF PET ARE EXPECTED TO DRIVE THE GROWTH OF THAILAND VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 28 THE GROWING PREVALENCE OF ANIMAL DISEASES IS EXPECTED TO DRIVE THE GROWTH OF PHILIPPINES VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 29 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF INDIA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 30 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF AUSTRALIA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 31 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF CHINA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 32 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF INDONESIA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 33 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MALAYSIA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 34 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF NEW ZEALAND VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 35 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF KOREA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 36 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF VIETNAM VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 37 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THAILAND VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 38 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF VIETNAM VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 39 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET
FIGURE 40 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 41 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 42 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 43 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 44 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 45 NEW ZEALAND VETERINARY MEDICINES MARKET: BY PRODUCT, 2022
FIGURE 46 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 47 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 48 THAILAND VETERINARY MEDICINES MARKET: BY PRODUCT, 2022
FIGURE 49 PHILIPPINES VETERINARY MEDICINES MARKET: BY PRODUCT, 2022
FIGURE 50 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 51 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 52 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 53 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 54 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 55 NEW ZEALAND VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 56 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 57 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 58 THAILAND VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 59 PHILIPPINES VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 60 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 61 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 62 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 63 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 64 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 65 NEW ZEALAND VETERINARY MEDICINES MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 66 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 67 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 68 THAILAND VETERINARY MEDICINES MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 69 PHILIPPINES VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 70 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 71 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 72 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 73 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 74 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 75 NEW ZEALAND VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 76 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 77 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 78 THAILAND VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 79 PHILIPPINES VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 80 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 81 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 82 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 83 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 84 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 85 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 86 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 87 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 88 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 89 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 90 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 91 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 92 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 93 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 94 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 95 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 96 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 97 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 98 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 99 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 100 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 101 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 102 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 103 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 104 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 105 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 106 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 107 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 108 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 109 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 110 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 111 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 112 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 113 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 114 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 115 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 116 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 117 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 118 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 119 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 120 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 121 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 122 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 123 INDONESIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 124 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 125 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 126 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 127 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 128 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 129 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 130 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 131 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 132 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 133 INDONESIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 134 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 135 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 136 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 137 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 138 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 139 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 140 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 141 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 142 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 143 INDONESIA IMMUNODIAGNOSTICS SMARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 144 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 145 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 146 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 147 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 148 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 149 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 150 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 151 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 152 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 153 INDONESIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 154 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 155 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 156 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 157 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 158 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 159 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 160 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 161 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 162 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 163 INDONESIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 164 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 165 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 166 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 167 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 168 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 169 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 170 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 171 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 172 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 173 INDONESIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 174 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 175 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 176 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 177 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 178 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 179 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 180 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 181 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 182 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 183 INDONESIA IMMUNODIAGNOSTICS SMARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 184 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 185 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 186 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 187 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 188 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 189 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 190 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 191 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 192 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 193 INDONESIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 194 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 195 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 196 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 197 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 198 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 199 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 200 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 201 AUSTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 202 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 203 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 204 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 205 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 206 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 207 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 208 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 209 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 210 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 211 AUSTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 212 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 213 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 214 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 215 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 216 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 217 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 218 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 219 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 220 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 221 AUSTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 222 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 223 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 224 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 225 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 226 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 227 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 228 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 229 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 230 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 231 ASUTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 232 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 233 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 234 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 235 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 236 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 237 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 238 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 239 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 240 INDIA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 241 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 242 CHINA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 243 INDONESIA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 244 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 245 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 246 KOREA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 247 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 248 THAILAND VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 249 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 250 INDIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 251 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 252 CHINA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 253 INDONESIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 254 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 255 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 256 KOREA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 257 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 258 THAILAND VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 259 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 260 INDIA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 261 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 262 CHINA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 263 INDONESIA IMMUNODIAGNOSTICS SMARKET: BY END USER, CAGR (2023-2030)
FIGURE 264 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 265 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 266 KOREA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 267 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 268 THAILAND VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 269 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 270 INDIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 271 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 272 CHINA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 273 INDONESIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 274 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 275 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 276 KOREA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 277 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 278 THAILAND VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 279 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 280 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 281 AUSTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 282 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 283 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 284 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 285 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 286 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL ,2022
FIGURE 287 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 288 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 289 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 290 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 291 AUSTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 292 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 293 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 294 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 295 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 296 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 297 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 298 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 299 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 300 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 301 AUSTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 302 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 303 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 304 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 305 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 306 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 307 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 308 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 309 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 310 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 311 ASUTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 312 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 313 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 314 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 315 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 316 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 317 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 318 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 319 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 320 INDIA VETERINARY MARKET: COMPANY SHARE 2022 (%)
FIGURE 321 AUSTRALIA VETERINARY MARKET: COMPANY SHARE 2022 (%)
FIGURE 322 CHINA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 323 INDONESIA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 324 MALAYSIA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 325 NEW ZEALAND VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 326 KOREA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 327 VIETNAM VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 328 THAILAND VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 329 PHILIPPINES VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
